Comparison Between D&C and Hysteroscopy in Management of AUB in Perimenopausal Women

Mohamed Sayed Abdelhafez

Status

Completed

Conditions

Uterine Bleeding

Treatments

Procedure: Hysteroscopy

Procedure: D&C

Study type

Interventional

Funder types

Other

Identifiers

NCT02705222

SMM

Details and patient eligibility

About

The aim of this study is to compare dilatation and curettage with hysteroscopy in obtaining an accurate diagnosis of the etiology of abnormal uterine bleeding and outlining a mode of treatment-specific to the cause.

Full description

Perimenopausal women complaining of abnormal uterine bleeding will be selected for assessment through detailed history taking, general and abdominal examination, local gynecological examination, transvaginal sonography (TVS) scanning and routine blood investigations. Eligible participants in our study will be those who complain of menorrhagia, metrorrhagia, polymenorrhoea or polymenorrhagia without local gynecological cause with failure of medical treatment for at least 3 months. All women participating in the study will be randomly allocated into two groups; dilatation and curettage (D&C) group and hysteroscopy group. For women in the D&C group, cervical dilatation and fractional endometrial curettage will be done under total intravenous (IV) anesthesia in operation theater and the curetting will be sent for histopathological examination. For women in the hysteroscopy group, hysteroscopy will be done under total IV anesthesia in operation theater hysteroscopic-guided curettings will also be taken and sent for histopathological examination.

Enrollment

100 patients

Sex

Female

Ages

45 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Perimenopausal women complaining of abnormal uterine bleeding (menorrhagia, metrorrhagia, polymenorrhoea or polymenorrhagia) without local gynecological cause.
Failure of medical treatment for at least 3 months.

Exclusion criteria

Age < 45 or > 55 years.
Blood disorders or coagulopathy.
Diagnosed or suspected local gynecologic lesion (polyp, adenomyosis, myoma, malignancy or cervical pathology).
Use intrauterine contraceptive device.
Pregnancy related conditions.